| RS387906589 |
ACVR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myositis ossificans, Inborn genetic diseases |
| RS387906590 |
ACVR1
|
Health Risk |
Pathogenic |
Progressive myositis ossificans, Progressive myositis ossificans |
| RS387906591 |
ACVR1
|
Health Risk |
Pathogenic |
Progressive myositis ossificans, Progressive myositis ossificans |
| RS387906592 |
ACTA2
|
Health Risk |
Pathogenic |
Multisystemic smooth muscle dysfunction syndrome, Moyamoya disease 5 |
| RS387906593 |
IFNGR1
|
Health Risk |
Pathogenic |
Immunodeficiency 27A, Immunodeficiency 27A |
| RS387906594 |
ATP2A2
|
Health Risk |
Pathogenic |
Acrokeratosis verruciformis of Hopf, Acrokeratosis verruciformis of Hopf |
| RS387906595 |
BLVRA
|
Health Risk |
Pathogenic |
Hyperbiliverdinemia, Hyperbiliverdinemia |
| RS387906596 |
BLVRA
|
Health Risk |
Pathogenic |
Hyperbiliverdinemia, Hyperbiliverdinemia |
| RS387906597 |
BMP4
|
Health Risk |
Pathogenic |
Orofacial cleft 11, Microphthalmia with brain and digit anomalies |
| RS387906598 |
CA8
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS387906599 |
CHN1
|
Health Risk |
Pathogenic |
Duane retraction syndrome 2, Duane retraction syndrome 2 |
| RS387906601 |
CYP11A1
|
Health Risk |
Pathogenic |
Congenital adrenal insufficiency with 46, XY sex reversal OR 46 |
| RS387906602 |
COL4A2
|
Health Risk |
Pathogenic |
Porencephaly 2, Porencephaly 2 |
| RS387906603 |
COL4A2
|
Health Risk |
Pathogenic |
Porencephaly 2, Porencephaly 2 |
| RS387906604 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica inversa, autosomal recessive |
| RS387906605 |
COL7A1
|
Health Risk |
Pathogenic |
Transient bullous dermolysis of the newborn, Transient bullous dermolysis of the newborn |
| RS387906606 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS387906608 |
COL6A2
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1B, Ullrich congenital muscular dystrophy 1B |
| RS387906609 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, BETHLEM MYOPATHY 1B |
| RS387906610 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS387906611 |
COL11A1
|
Health Risk |
Pathogenic |
Fibrochondrogenesis, Fibrochondrogenesis |
| RS387906612 |
GJA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS387906613 |
GJA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS387906614 |
GJA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS387906615 |
GJA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS387906616 |
GJA1
|
Health Risk |
Pathogenic |
Oculodentodigital dysplasia, Oculodentodigital dysplasia |
| RS387906618 |
DSP
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS387906619 |
DHFR
|
Health Risk |
Pathogenic |
Constitutional megaloblastic anemia with severe neurologic disease, Constitutional megaloblastic anemia with severe neurologic disease |
| RS387906620 |
NT5E
|
Health Risk |
Pathogenic |
Hereditary arterial and articular multiple calcification syndrome, Hereditary arterial and articular multiple calcification syndrome |
| RS387906621 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS387906622 |
FBN1
|
Health Risk |
Pathogenic |
Acromicric dysplasia, Geleophysic dysplasia 2 |
| RS387906623 |
FBN1
|
Health Risk |
Likely pathogenic |
Geleophysic dysplasia 2, Familial thoracic aortic aneurysm and aortic dissection |
| RS387906624 |
FBN1
|
Health Risk |
Pathogenic |
Geleophysic dysplasia 2, Acromicric dysplasia |
| RS387906625 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Geleophysic dysplasia 2, Familial thoracic aortic aneurysm and aortic dissection |
| RS387906626 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Acromicric dysplasia, Marfan syndrome |
| RS387906627 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS387906628 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Amyotrophic lateral sclerosis type 6 |
| RS387906629 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Leukemia |
| RS387906631 |
GATA2
|
Health Risk |
Likely pathogenic |
Myelodysplastic syndrome, Leukemia |
| RS387906632 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS387906633 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS387906634 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS387906635 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS387906636 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS387906637 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS387906639 |
HARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3B, Inborn genetic diseases |
| RS387906640 |
KRT10
|
Health Risk |
Pathogenic |
Epidermolytic hyperkeratosis 2B, autosomal recessive |
| RS387906641 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS387906642 |
KIF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS387906643 |
KIF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS387906644 |
LAMB2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, Pierson syndrome |
| RS387906645 |
MSR1
|
Health Risk |
Pathogenic |
BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA, BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA |
| RS387906646 |
MAK
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 62, Retinal dystrophy |
| RS387906647 |
MAK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 62, Retinal dystrophy |
| RS387906648 |
MAK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 62, Retinitis pigmentosa |
| RS387906649 |
MAX
|
Health Risk |
Pathogenic |
Pheochromocytoma, susceptibility to |
| RS387906650 |
MAX
|
Health Risk |
Pathogenic |
Pheochromocytoma, susceptibility to |
| RS387906651 |
MAX
|
Health Risk |
Pathogenic |
Pheochromocytoma, susceptibility to |
| RS387906652 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS387906653 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS387906654 |
SLC20A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS387906655 |
MOG
|
Health Risk |
Pathogenic |
Narcolepsy 7, Narcolepsy 7 |
| RS387906657 |
MYBPC1
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS387906658 |
MYBPC1
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS387906659 |
AKT2
|
Health Risk |
Pathogenic |
Hypoinsulinemic hypoglycemia and body hemihypertrophy, Type 2 diabetes mellitus |
| RS387906660 |
BRAF
|
Health Risk |
Pathogenic |
Noonan syndrome 7, Noonan syndrome 1 |
| RS387906661 |
BRAF
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 1, LEOPARD syndrome 3 |
| RS387906662 |
CSF1R
|
Health Risk |
Pathogenic |
Hereditary diffuse leukoencephalopathy with spheroids, Hereditary diffuse leukoencephalopathy with spheroids |
| RS387906663 |
WNT5A
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 1 |
| RS387906664 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia, RASopathy |
| RS387906665 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia, RASopathy |
| RS387906666 |
CBL
|
Health Risk |
Likely pathogenic |
Juvenile myelomonocytic leukemia, Noonan syndrome-like disorder with juvenile myelomonocytic leukemia |
| RS387906667 |
PRRX1
|
Health Risk |
Pathogenic |
Agnathia-otocephaly complex, Agnathia-otocephaly complex |
| RS387906668 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS387906669 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS387906670 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS387906673 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS387906674 |
PROS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombophilia due to protein S deficiency, autosomal dominant |
| RS387906675 |
PROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS387906676 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Crouzon syndrome, FGFR2-related craniosynostosis |
| RS387906677 |
FGFR2
|
Health Risk |
Pathogenic |
Bent bone dysplasia syndrome 1, Bent bone dysplasia syndrome 1 |
| RS387906678 |
FGFR2
|
Health Risk |
Likely pathogenic |
Bent bone dysplasia syndrome 1, Inborn genetic diseases |
| RS387906679 |
PRKCG
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 14, Spinocerebellar ataxia type 14 |
| RS387906680 |
PSMB8
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 1, Proteasome-associated autoinflammatory syndrome 1 |
| RS387906682 |
SLC5A2
|
Health Risk |
Pathogenic |
Familial renal glucosuria, Familial renal glucosuria |
| RS387906683 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS387906684 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS387906685 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS387906686 |
SCN2A
|
Health Risk |
Likely pathogenic |
Episodic ataxia, type 9 |
| RS387906687 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS387906688 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS387906689 |
CSTA
|
Health Risk |
Pathogenic |
Peeling skin syndrome 4, Peeling skin syndrome 4 |
| RS387906690 |
NR5A1
|
Health Risk |
Pathogenic |
Spermatogenic failure 8, Spermatogenic failure 8 |
| RS387906691 |
TBXA2R
|
Health Risk |
risk factor |
Bleeding disorder, platelet-type |
| RS387906692 |
PRKAR1A
|
Health Risk |
Pathogenic |
Acrodysostosis 1 with or without hormone resistance, Carney complex |
| RS387906694 |
PRKAR1A
|
Health Risk |
Pathogenic |
Acrodysostosis 1 with or without hormone resistance, Acrodysostosis 1 with or without hormone resistance |
| RS387906695 |
PRKAR1A
|
Health Risk |
Pathogenic |
Acrodysostosis 1 with or without hormone resistance, Acrodysostosis 1 with or without hormone resistance |
| RS387906697 |
TGFBR1
|
Health Risk |
Pathogenic |
Multiple self-healing squamous epithelioma, Familial thoracic aortic aneurysm and aortic dissection |
| RS387906698 |
PRSS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS387906700 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome |